LIVER METASTASES

This trial is testing a device called the HistoSonics System, which uses focused ultrasound waves to destroy liver tumors without surgery. The study aims to see if this non-invasive treatment is safe and effective for patients with liver cancer who haven't responded well to other…

This study compares two different non-surgical treatments for colorectal cancer that has spread to the liver. It tests whether targeted radiation therapy or a heat-based ablation technique works better to control tumor growth. The trial involves 100 patients with 1-3 small liver …

This trial is testing a device called the HistoSonics System, which uses focused ultrasound waves to destroy liver tumors without surgery or radiation. It's for adults with liver cancer or tumors that have spread to the liver from other cancers, who haven't responded well to othe…

This study is testing whether a medication called QBECO, given as injections before and after surgery to remove colorectal cancer that has spread to the liver, can help keep the cancer from coming back. About 115 participants will receive either QBECO or a placebo (inactive subst…

This study is testing how well two drugs, atezolizumab and bevacizumab, work for people with inoperable liver cancer or non-small cell lung cancer that has spread to the liver. Researchers will measure how long it takes for the cancer to worsen and will collect blood and tumor sa…

This study is testing new artificial intelligence (AI) software designed to improve the quality of CT scan images of the liver. The goal is to see if these AI-enhanced images, taken with a lower dose of radiation, can detect liver metastases (cancer spread) as accurately as stand…

This study is testing whether a guided exercise program is safe, practical, and acceptable for older adults with liver cancer who are planning to have surgery. The main goal is to see if patients can and will participate in the program before their operation. Researchers will mea…

This small study is testing a new type of PET scan to see if it can predict which patients with advanced HER2-positive breast cancer will benefit from a specific drug treatment. Researchers attach a tiny radioactive tag to a cancer drug and use a scanner to see where it goes in t…